Literature DB >> 23407470

Vaginal swabs are the optimal specimen for detection of genital Chlamydia trachomatis or Neisseria gonorrhoeae using the Cobas 4800 CT/NG test.

Barbara Van Der Pol1, Stephanie N Taylor, Oliver Liesenfeld, James A Williams, Edward W Hook.   

Abstract

Performance characteristics of the Cobas 4800 CT/NG assay were estimated for vaginal swab samples from more than 4000 women. Vaginal samples identified 92.9% and 98.5% of Chlamydia and Gonorrhea infections, respectively, which was more than any other single specimen type (endocervical swabs or urine) regardless of collection method (clinician collected or self-obtained).

Entities:  

Mesh：

Year:  2013        PMID： 23407470     DOI： 10.1097/OLQ.0b013e3182717833

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


  13 in total

Review 1.  Emerging technologies for the clinical microbiology laboratory.

Authors:  Blake W Buchan; Nathan A Ledeboer
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 2.  [Non-viral sexually transmitted infections - Epidemiology, clinical manifestations, diagnostics and therapy : Part 1: Gonococci].

Authors:  P Nenoff; A Manos; I Ehrhard; C Krüger; U Paasch; P Helmbold; W Handrick
Journal:  Hautarzt       Date:  2017-01       Impact factor: 0.751

Review 3.  Point of care diagnostics for sexually transmitted infections: perspectives and advances.

Authors:  Charlotte Gaydos; Justin Hardick
Journal:  Expert Rev Anti Infect Ther       Date:  2014-02-03       Impact factor: 5.091

4.  Head-to-head comparison of second-generation nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae on urine samples from female subjects and self-collected vaginal swabs.

Authors:  Max Chernesky; Dan Jang; Jodi Gilchrist; Todd Hatchette; André Poirier; Jean-Frederic Flandin; Marek Smieja; Sam Ratnam
Journal:  J Clin Microbiol       Date:  2014-04-02       Impact factor: 5.948

5.  Chlamydia trachomatis in Iceland: Prevalence, Clinico-epidemiological Features and Comparison of Cobas 480 CT/NG and Aptima Combo 2 (CT/NG) for Diagnosis.

Authors:  Ingibjorg Hilmarsdóttir; Eva Mjöll Arnardóttir; Elísabet Reykdal Jóhannesdóttir; Daniel Golparian; Magnus Unemo
Journal:  Acta Derm Venereol       Date:  2021-02-11       Impact factor: 3.875

6.  Natural Course of Chlamydia trachomatis Bacterial Load in the Time Interval between Screening and Treatment in Anogenital Samples.

Authors:  J A M C Dirks; G A F S van Liere; S Bogers; N H T M Dukers-Muijrers; P F G Wolffs; C J P A Hoebe
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

7.  Loop-mediated isothermal amplification of Neisseria gonorrhoeae porA pseudogene: a rapid and reliable method to detect gonorrhea.

Authors:  Mei-Ling Liu; Yong Xia; Xing-Zhong Wu; Jian-Qiong Huang; Xu-Guang Guo
Journal:  AMB Express       Date:  2017-02-23       Impact factor: 3.298

8.  High-Throughput Testing of Urogenital and Extragenital Specimens for Detection of Chlamydia Trachomatis and Neisseria Gonorrhoeae with Cobas® CT/NG.

Authors:  Elizabeth M Marlowe; David Hardy; Mark Krevolin; Peter Gohl; Alexander Bertram; Rodney Arcenas; Britta Seiverth; Tanja Schneider; Oliver Liesenfeld
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2017-09-11

9.  Evaluation of the Performance of the Cobas CT/NG Test for Use on the Cobas 6800/8800 Systems for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Male and Female Urogenital Samples.

Authors:  Barbara Van Der Pol; Kenneth Fife; Stephanie N Taylor; Melinda B Nye; Steven E Chavoustie; David L Eisenberg; LaShonda Crane; Gregory Hirsch; Rodney Arcenas; Elizabeth M Marlowe
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

10.  Evaluation of the performance of nucleic acid amplification tests (NAATs) in detection of chlamydia and gonorrhoea infection in vaginal specimens relative to patient infection status: a systematic review.

Authors:  Minttu M Rönn; Louise Mc Grath-Lone; Bethan Davies; Janet D Wilson; Helen Ward
Journal:  BMJ Open       Date:  2019-01-17       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.